100+ Free Título de Especialista em Gastroenterologia (FBG) Practice Questions

Prepare for the Título de Especialista em Gastroenterologia — Federação Brasileira de Gastroenterologia (FBG / AMB) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Brazilian Medical Association Specialty Title Concursos (AMB / Título de Especialista)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

CBR Prova de Título de Especialista em Radiologia e Diagnóstico por Imagem (Brazil)

Practice Questions100 questions

2026 Statistics

Key Facts: Título de Especialista em Gastroenterologia (FBG) Exam

Set by edital

FBG publishes the paper structure, cut score and fee in a numbered edital for each edition; no standing figures are published

Edital FBG — Título de Especialista em Gastroenterologia

4 Hours

Theoretical Examination Duration

Edital Oficial FBG / AMB

Set by edital

FBG publishes the paper structure, cut score and fee in a numbered edital for each edition; no standing figures are published

Edital FBG — Título de Especialista em Gastroenterologia

2 Phases

Prova Teórica + Prova Prática / Teórico-Prática

Comissão de Título de Especialista FBG

RQE CFM

Specialist Qualification Registry (CFM/CRM)

Conselho Federal de Medicina

Baveno VII

Standard Portal Hypertension Guidance

Consenso Internacional / FBG

PCDT MS

Protoc. Clínicos e Diretrizes Terapêuticas

Ministério da Saúde do Brasil

Chicago v4.0

High-Resolution Manometry Protocol

International HRM Working Group

The Título de Especialista em Gastroenterologia (FBG / AMB) is Brazil's premier board certification in Gastroenterology, qualifying physicians for the official CFM RQE. It features an 80-question Prova Teórica and a multimedia Prova Prática requiring a 70% passing grade. This 100-question practice bank provides a rigorous English-language adaptation covering Hepatology, Cirrhosis, IBD, Luminal, Biliary-Pancreatic, and Gut-Brain Axis disorders.

Sample Título de Especialista em Gastroenterologia (FBG) Practice Questions

Try these sample questions to test your Título de Especialista em Gastroenterologia (FBG) exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 42-year-old woman with typical heartburn and regurgitation symptoms for two years undergoes upper endoscopy showing normal esophageal mucosa (Los Angeles grade 0). She is referred for 24-hour ambulatory pH-impedance monitoring performed off proton pump inhibitor (PPI) therapy. According to the Lyon Consensus 2.0, which of the following findings provides conclusive evidence of Gastroesophageal Reflux Disease (GERD)?

A.Total Acid Exposure Time (AET) greater than 6.0% with more than 80 total reflux episodes over 24 hours.

B.Mean Nocturnal Baseline Impedance (MNBI) between 2,200 and 2,500 ohms with normal total AET.

C.A total of 45 reflux episodes with a negative Symptom Association Probability (SAP < 90%).

D.Total Acid Exposure Time (AET) of 3.2% with a Post-Reflux Swallow-Induced Peristaltic Wave (PSPW) index of 65%.

Explanation: Under the Lyon Consensus 2.0 guidelines, conclusive evidence of GERD on unmedicated 24-hour ambulatory pH-impedance monitoring requires a total Acid Exposure Time (AET) > 6.0% (or severe erosive esophagitis Los Angeles grades C/D or long-segment Barrett's on endoscopy). Elevated reflux episodes (> 80/24h) and low MNBI (< 1,500 ohms) provide supportive evidence of pathologic reflux burden. An AET < 4.0% is considered definitively physiologic/normal, while 4.0%–6.0% represents a borderline/inconclusive gray zone.

2A 58-year-old male with a 15-year history of chronic GERD undergoes screening endoscopy. The endoscopist identifies salmon-colored columnar mucosa extending 3 cm circumferentially and reaching a maximal extent of 5 cm above the gastroesophageal junction (Prague C3M5). Biopsies confirm intestinal metaplasia with goblet cells and no dysplasia. According to standard gastroenterology guidelines, what is the appropriate surveillance strategy?

A.Repeat high-definition upper endoscopy with 4-quadrant biopsies every 2 cm (Seattle protocol) in 3 to 5 years.

B.Perform immediate radiofrequency ablation (RFA) to eliminate non-dysplastic Barrett's esophagus.

C.Perform repeat endoscopy in 6 months with 4-quadrant biopsies every 1 cm.

D.Discontinue endoscopic surveillance because non-dysplastic Barrett's esophagus carries zero progression risk.

Explanation: For confirmed non-dysplastic Barrett's esophagus (NDBE) with intestinal metaplasia, international and Brazilian guidelines recommend endoscopic surveillance every 3 to 5 years using high-definition white-light endoscopy and the Seattle biopsy protocol (4-quadrant biopsies every 2 cm along the columnar segment). Endoscopic ablation is reserved for confirmed low-grade dysplasia (optional) or high-grade dysplasia/early neoplasia.

3A 35-year-old man presents with progressive dysphagia for both solids and liquids and unprovoked regurgitation. High-Resolution Esophageal Manometry (HRM) reveals an elevated median Integrated Relaxation Pressure (IRP = 28 mmHg, normal < 15 mmHg) and 100% failed peristalsis, with panesophageal pressurization observed in 40% of test swallows. Under the Chicago Classification v4.0, what is the definitive motility diagnosis?

A.Type II Achalasia (Achalasia with panesophageal pressurization).

B.Type I Achalasia (Classic achalasia with 100% absent peristalsis and no pressurization).

C.Type III Achalasia (Spastic achalasia with premature/spastic contractions).

D.Esophagogastric Junction Outflow Obstruction (EGJOO) with intact peristalsis.

Explanation: Under the Chicago Classification v4.0, Type II Achalasia is defined by an elevated median IRP (impaired lower esophageal sphincter relaxation) accompanied by 100% failed peristalsis and panesophageal pressurization occurring in ≥ 20% of test swallows. Type II achalasia is the most common subtype and has the highest response rate to pneumatic dilation, Heller myotomy, and POEM.

4A 26-year-old atopic male presents with intermittent solid-food dysphagia and an episode of food impaction requiring endoscopic meat bolus extraction. Endoscopy reveals circular esophageal rings ('trachealization'), linear furrows, and white exudative plaques. Esophageal mucosal biopsies show 25 eosinophils per high-power field (HPF). What is the first-line management protocol for this patient?

A.High-dose proton pump inhibitor (PPI) therapy or swallowed topical corticosteroids (fluticasone/budesonide) or an empiric food elimination diet.

B.Immediate pneumatic balloon dilation to 35 mm to disrupt the muscularis propria.

C.Continuous oral systemic prednisone 60 mg/day for 12 months as maintenance therapy.

D.Subtotal esophagectomy with gastric pull-up due to high risk of transmural perforation.

Explanation: The clinical, endoscopic, and histological presentation (≥ 15 eosinophils/HPF) establishes the diagnosis of Eosinophilic Esophagitis (EoE). First-line treatment options include high-dose PPI twice daily, topical swallowed corticosteroids (fluticasone or viscous budesonide slurry), or dietary elimination (e.g., 2-, 4-, or 6-food elimination diets). Dilation is reserved for symptomatic dominant fibrostenotic strictures refractory to medical therapy.

5A 62-year-old patient born in a rural area of Minas Gerais, Brazil, presents with a 5-year history of worsening dysphagia, regurgitation, and weight loss. A barium esophagogram demonstrates an esophageal diameter of 6.5 cm with marked distal tapering ('bird-beak' sign), tortuosity, and significant barium retention (Rezende Classification Group III). Serology for Trypanosoma cruzi (ELISA and indirect immunofluorescence) is positive. What is the underlying pathophysiology of Chagasic megaesophagus?

A.Parasite-mediated destruction of the myenteric (Auerbach's) nerve plexus leading to loss of inhibitory nitrergic neurons and aperistalsis.

B.Direct autoimmune destruction of the circular smooth muscle layers sparing the intramural neural plexus.

C.Hypertrophy of the vagal motor nucleus in the brainstem causing secondary lower esophageal sphincter hypertonia.

D.Deposition of IgA immune complexes in the esophageal submucosa causing severe fibrostenosis.

Explanation: Chagasic megaesophagus results from Trypanosoma cruzi infection causing severe inflammatory destruction and denervation of the intramural myenteric (Auerbach's) nerve plexus throughout the esophagus. The loss of inhibitory postganglionic neurons that produce nitric oxide and VIP leads to failure of lower esophageal sphincter (LES) relaxation and progressive loss of esophageal peristalsis, identical manometrically to idiopathic achalasia.

6A 54-year-old woman with severe non-cardiac retrosternal chest pain and intermittent dysphagia undergoes High-Resolution Manometry. The tracing shows a normal median IRP (9 mmHg), but 40% of test swallows exhibit a Distal Contractile Integral (DCI) exceeding 10,000 mmHg·s·cm with normal distal latency (DL > 4.5 seconds). According to the Chicago Classification v4.0, what is this disorder?

A.Hypercontractile (Jackhammer) Esophagus.

B.Distal Esophageal Spasm (DES).

C.Type III (Spastic) Achalasia.

D.Ineffective Esophageal Motility (IEM).

Explanation: Hypercontractile (Jackhammer) Esophagus is defined under Chicago Classification v4.0 as ≥ 20% of swallows with hypercontractility (DCI > 8,000 mmHg·s·cm) and normal distal latency (DL ≥ 4.5 seconds) in the presence of a normal median IRP. In contrast, Distal Esophageal Spasm requires premature contractions (DL < 4.5 seconds) in ≥ 20% of swallows.

7A 38-year-old HIV-positive patient with a CD4 count of 45 cells/mm³ presents with severe odynophagia and retrosternal pain. Upper endoscopy demonstrates multiple large, shallow, linear/longitudinal ulcers with discrete erythematous margins in the mid-to-distal esophagus. Biopsies taken from the ulcer base reveal endothelial and mesenchymal giant cells with large intranuclear inclusion bodies ('owl's eye' appearance). What is the definitive pathogen and first-line treatment?

A.Cytomegalovirus (CMV) esophagitis; treat with intravenous Ganciclovir.

B.Herpes Simplex Virus (HSV) esophagitis; treat with oral Acyclovir.

C.Candida albicans esophagitis; treat with oral Fluconazole.

D.Human Papillomavirus (HPV) esophagitis; treat with topical Imiquimod.

Explanation: Cytomegalovirus (CMV) esophagitis in immunocompromised patients typically manifests as large, solitary, deep or linear ulcers. Histopathology demonstrates enlarged endothelial and stromal cells with pathognomonic basophilic intranuclear inclusions ('owl's eye') located at the ulcer base. Intravenous Ganciclovir (5 mg/kg IV q12h) is the treatment of choice.

8A 74-year-old man presents with progressive high oropharyngeal dysphagia, halitosis, nocturnal cough, and regurgitation of undigested food eaten hours earlier. Physical examination reveals a soft, compressible mass on the left side of the neck that produces a gurgling sound upon palpation (Boyce's sign). Barium swallow confirms a posterior pouch originating above the cricopharyngeus muscle. What anatomical space is involved in this condition (Zenker's Diverticulum)?

A.Killian's triangle (between the thyropharyngeus and cricopharyngeus muscles).

B.Laimer's triangle (between the cricopharyngeus muscle and circular esophageal fibers).

C.Killian-Jamieson space (anterolateral wall below the cricopharyngeus).

D.Morgagni's foramen (anterior diaphragmatic defect).

Explanation: Zenker's diverticulum is a false (pulsion) diverticulum arising from a zone of anatomical weakness in the posterior hypopharyngeal wall known as Killian's triangle (bounded superiorly by the oblique fibers of the thyropharyngeus muscle and inferiorly by the transverse fibers of the cricopharyngeus muscle). Pathophysiology involves uncoordinated cricopharyngeal relaxation and elevated intrabolus pressure.

9During an upper gastrointestinal endoscopy, a gastroenterologist notes mucosal breaks in the distal esophagus. Two distinct breaks measure 4 mm each and are confined to mucosal mucosal folds without extending between the tops of two mucosal folds. According to the Los Angeles Classification of Gastroesophageal Reflux Disease, what is the grade?

A.Los Angeles Grade A.

B.Los Angeles Grade B.

C.Los Angeles Grade C.

D.Los Angeles Grade D.

Explanation: Under the Los Angeles Classification: Grade A corresponds to one or more mucosal breaks ≤ 5 mm in length that do not extend between the tops of two mucosal folds. Grade B is defined as one or more mucosal breaks > 5 mm that do not bridge mucosal folds. Grade C involves continuous mucosal breaks bridging the tops of ≥ 2 mucosal folds involving < 75% of the esophageal circumference. Grade D involves mucosal breaks involving ≥ 75% of the circumference.

10A 48-year-old man with persistent heartburn despite standard once-daily omeprazole 20 mg taken at bedtime undergoes evaluation for refractory GERD. What is the most appropriate initial pharmacological adjustment according to gastroenterology guidelines?

A.Optimize PPI therapy by doubling the dose to 20 mg twice daily, taken 30 to 60 minutes before breakfast and dinner.

B.Immediately switch the patient to oral sucralfate suspension 1 g four times daily as monotherapy.

C.Add oral baclofen 20 mg TID and metoclopramide 10 mg TID without changing the PPI schedule.

D.Refer the patient directly for total fundoplication surgery without further clinical or diagnostic optimization.

Explanation: The first step in evaluating and managing refractory GERD is optimizing PPI therapy: ensuring correct timing (30–60 minutes before meals to coincide with peak proton pump activation) and increasing to a twice-daily dosing regimen (before breakfast and before the evening meal). Switching to a more potent PPI or doubling the dose achieves symptom relief in a significant proportion of refractory cases.

About the Título de Especialista em Gastroenterologia (FBG) Exam

The Título de Especialista em Gastroenterologia (TEG) is the official medical board certification awarded jointly by the Federação Brasileira de Gastroenterologia (FBG) and the Associação Médica Brasileira (AMB), recognized by the Conselho Federal de Medicina (CFM) for the registration of the Specialist Qualification Record (RQE - Registro de Qualificação de Especialista em Gastroenterologia). The federation fixes the structure, duration and cut score of each edition in its numbered edital rather than publishing standing figures.

Assessment

Concurso para o Título de Especialista em Gastroenterologia run by the Federação Brasileira de Gastroenterologia (FBG) with the AMB under an annual edital. This credential is distinct from the SOBED endoscopy título and from the CBCD's TECAD in Cirurgia do Aparelho Digestivo: the three overlap clinically but are separate credentials with separate editais and separate societies.

Time Limit

Set by each annual edital

Passing Score

Set by each edition's edital

Exam Fee

Set annually by the society's edital and varies with society/AMB membership status; consult the current edital before budgeting (Federação Brasileira de Gastroenterologia (FBG) — Associação Médica Brasileira (AMB))

Título de Especialista em Gastroenterologia (FBG) Exam Content Outline

20%

Esofagogastroduodeno e Doenças Ácido-Pépticas

Pathophysiology and management of GERD under Lyon Consensus 2.0, ambulatory 24h pH-impedance monitoring parameters, Los Angeles grading of erosive esophagitis, Barrett's esophagus surveillance (Prague criteria and Seattle protocol), High-Resolution Manometry Chicago Classification v4.0 (Achalasia Types I, II, III, Jackhammer esophagus, Distal Esophageal Spasm), Eosinophilic Esophagitis (EoE diagnostic threshold ≥15 eos/HPF and medical/dietary treatments), Helicobacter pylori diagnostic testing and the 4th Brazilian Consensus quadruple eradication regimens, peptic ulcer hemorrhage endoscopic triage (Forrest classification), autoimmune atrophic gastritis (anti-parietal cell and intrinsic factor antibodies, OLGA/OLGIM staging), and gastric polyps.

25%

Hepatologia Clínica e Doenças Hepáticas Crônicas

Comprehensive clinical hepatology: Chronic Hepatitis B natural history, serology, viral load, and PCDT Ministério da Saúde antiviral therapy indications (entecavir, tenofovir TDF/TAF); Chronic Hepatitis C pan-genotypic Direct-Acting Antiviral (DAA) regimens and post-SVR12 hepatocellular carcinoma surveillance; Hepatitis Delta virus (HDV); Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD/MASH) risk stratification (FIB-4, transient elastography FibroScan, resmetirom); Autoimmune Hepatitis (AIH) simplified diagnostic criteria; Primary Biliary Cholangitis (PBC - AMA M2 antibodies, UDCA 13–15 mg/kg/day, second-line obeticholic acid/bezafibrate); Primary Sclerosing Cholangitis (PSC); Hereditary Hemochromatosis (HFE C282Y); Wilson's Disease; Drug-Induced Liver Injury (DILI - Hy's Law and R-ratio); and Hepatocellular Carcinoma (HCC - BCLC staging and Milan transplantation criteria).

20%

Cirrose Hepática e Complicações da Hipertensão Portal

Mechanisms and hemodynamics of portal hypertension (HVPG thresholds) and Baveno VII consensus criteria for non-invasive risk stratification (platelet count >150k and LSM <20 kPa); acute esophageal/gastric variceal hemorrhage resuscitation, pharmacotherapy (terlipressin, octreotide), endoscopic band ligation (EBL), and preemptive TIPS; Ascites pathophysiology, Serum-Ascites Albumin Gradient (SAAG ≥1.1 g/dL vs <1.1 g/dL), diuretic regimens, and refractory ascites; Spontaneous Bacterial Peritonitis (SBP - PMN ≥250/mm³, third-generation cephalosporins, IV albumin 1.5 g/kg Day 1 and 1.0 g/kg Day 3, secondary prophylaxis); Hepatorenal Syndrome (HRS-AKI criteria, volume challenge with 20% albumin, terlipressin infusion); and Hepatic Encephalopathy (West Haven grading, lactulose titration, rifaximin).

15%

Doenças Inflamatórias Intestinais (DII) e Intestino Delgado

Crohn's Disease and Ulcerative Colitis phenotypic classification (Montreal classification), STRIDE-II treat-to-target endpoints, endoscopic scoring (Mayo score, SES-CD), therapeutic drug monitoring, immunomodulators (azathioprine TPMT/NUDT15), biologic therapies (anti-TNF infliximab/adalimumab, anti-IL12/23 ustekinumab, anti-IL23 risankizumab/mirikizumab, anti-integrin vedolizumab), small molecules (JAK inhibitors upadacitinib/tofacitinib, S1P modulators), Acute Severe Ulcerative Colitis (ASUC) rescue therapy (IV corticosteroids, infliximab, cyclosporine), IBD colorectal cancer chromoendoscopy surveillance, Celiac Disease serology (anti-tTG IgA, EMA, total IgA) and histopathology (Marsh-Oberhuber classification), Small Intestinal Bacterial Overgrowth (SIBO / IMO breath testing and rifaximin), Short Bowel Syndrome (GLP-2 analog teduglutide), and Microscopic Colitis (budesonide therapy).

20%

Pâncreas, Vias Biliares e Gastroenterologia Funcional / Emergências

Acute Pancreatitis staging (Revised Atlanta Classification: mild, moderately severe, severe with persistent organ failure >48h), goal-directed fluid resuscitation with Ringer's lactate, step-up minimally invasive approach for infected walled-off necrosis (WON), indication for urgent ERCP in gallstone pancreatitis with cholangitis; Chronic Pancreatitis etiology (TIGAR-O classification), exocrine pancreatic insufficiency (fecal elastase-1 <200 mcg/g), and PERT dosing; Pancreatic Cystic Neoplasms (IPMN, MCN, SCA Fukuoka guidelines); Autoimmune Pancreatitis (Type 1 IgG4-related systemic disease vs Type 2); Acute Cholangitis (Tokyo Guidelines TG18 diagnosis, severity grading, urgent biliary drainage); Rome IV Functional GI Disorders (IBS-C, IBS-D, IBS-M, low-FODMAP diet, neuromodulators; Functional Dyspepsia PDS and EPS; dyssynergic defecation anorectal manometry and biofeedback); Lower GI Bleeding triage (Oakland score); and Clostridioides difficile infection management.

How to Pass the Título de Especialista em Gastroenterologia (FBG) Exam

What You Need to Know

Passing score: Set by each edition's edital
Assessment: Concurso para o Título de Especialista em Gastroenterologia run by the Federação Brasileira de Gastroenterologia (FBG) with the AMB under an annual edital. This credential is distinct from the SOBED endoscopy título and from the CBCD's TECAD in Cirurgia do Aparelho Digestivo: the three overlap clinically but are separate credentials with separate editais and separate societies.
Time limit: Set by each annual edital
Exam fee: Set annually by the society's edital and varies with society/AMB membership status; consult the current edital before budgeting

Keys to Passing

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Título de Especialista em Gastroenterologia (FBG) Study Tips from Top Performers

1Memorize Baveno VII and Cirrhosis Cutoffs: Know the non-invasive rule-out criteria for high-risk varices (platelet count >150,000/μL and Liver Stiffness Measurement <20 kPa), SAAG calculation (≥1.1 g/dL portal hypertension vs <1.1 g/dL non-portal causes), SBP diagnostic cutoff (≥250 PMN/mm³), and the mandatory IV albumin regimen for SBP (1.5 g/kg on day 1, 1.0 g/kg on day 3).

2Master the 4th Brazilian Consensus on H. pylori: Understand when to use bismuth vs non-bismuth quadruple therapy for 14 days as first-line eradication, and remember that post-eradication confirmation testing (urea breath test or stool antigen) requires stopping PPIs for at least 2 weeks and antibiotics/bismuth for at least 4 weeks.

3Understand Chicago Classification v4.0 for Esophageal Motility: Differentiate Achalasia Type I (classic, 100% failed peristalsis, no panesophageal pressurization), Type II (panesophageal pressurization in ≥20% of swallows), and Type III (spastic, premature contractions in ≥20% of swallows) with elevated median IRP, as well as Distal Esophageal Spasm and Hypercontractile (Jackhammer) Esophagus.

4Consolidate STRIDE-II and IBD Biologics Selection: Master evidence-based positioning of anti-TNF agents (infliximab, adalimumab), anti-IL12/23 (ustekinumab), anti-IL23 (risankizumab, mirikizumab), anti-integrin (vedolizumab), and oral JAK inhibitors (upadacitinib, tofacitinib) in moderate-to-severe Crohn's disease and Ulcerative Colitis, including primary non-response vs secondary loss of response management.

5Review Viral Hepatitis PCDT Guidelines: Master the diagnostic algorithms and antiviral treatment criteria for chronic Hepatitis B (HBeAg status, ALT elevation, HBV DNA >2,000 IU/mL, advanced fibrosis F2-F4, extrahepatic manifestations, immunosuppressive therapy prophylaxis) with entecavir or tenofovir, and pan-genotypic DAA regimens for Hepatitis C with SVR12 evaluation.

6Differentiate Pancreatic Cystic Lesions and IPMN Guidelines: Master the distinction between Serous Cystadenoma (benign, microcystic, central scar, low CEA, low amylase), Mucinous Cystic Neoplasm (pre-malignant, ovarian-like stroma, thick wall, elevated CEA, body/tail), and IPMN (main duct vs branch duct; high-risk stigmata requiring resection vs worrisome features requiring EUS-FNA surveillance).

Frequently Asked Questions

What is the Título de Especialista em Gastroenterologia (FBG / AMB)?

The Título de Especialista em Gastroenterologia is the official specialist title in clinical gastroenterology awarded by the Federação Brasileira de Gastroenterologia (FBG) in partnership with the Associação Médica Brasileira (AMB). Earning this title allows the physician to obtain the Registro de Qualificação de Especialista (RQE) in Gastroenterology from their Regional Council of Medicine (CRM) and the Conselho Federal de Medicina (CFM).

How does the FBG Gastroenterology title differ from the SOBED and CBCD titles?

The Brazilian medical qualification system maintains three distinct credentials: (1) Título de Especialista em Gastroenterologia awarded by FBG/AMB for clinical gastroenterology and hepatology; (2) Título de Especialista em Endoscopia Digestiva awarded by SOBED (Sociedade Brasileira de Endoscopia Digestiva)/AMB for diagnostic and therapeutic digestive endoscopy; and (3) Título de Especialista em Cirurgia do Aparelho Digestivo (TECAD) awarded by CBCD (Colégio Brasileiro de Cirurgia Digestiva)/AMB for digestive tract surgery. Each society publishes its own independent edital, prerequisites, and examination structure.

What is the examination structure and passing standard for the FBG title exam?

The FBG runs the concurso under a numbered edital issued for each edition, and does not publish a standing item count, duration or cut score. Candidates should read the current edital before relying on any figure. Keep this credential distinct from the SOBED endoscopy título and from the CBCD's TECAD in Cirurgia do Aparelho Digestivo: the three overlap clinically but are separate credentials awarded by separate societies under separate editais.

What are the eligibility prerequisites to register for the FBG title exam?

Candidates must hold an active CRM registration and satisfy one of two pathways: (1) Completion of a CNRM/MEC-accredited Medical Residency in Gastroenterology; or (2) Completion of an FBG-accredited specialization course plus documented clinical practice, or a minimum of 6 years of verified professional practice in Gastroenterology in Brazil with required scientific and continuing medical education credits.

Why is this practice question bank presented in English?

This practice bank is an English-language multiple-choice adaptation designed to support international-standard clinical knowledge synthesis, board preparation, and bilingual medical education while preserving exact official Portuguese terminology (such as FBG, AMB, CFM, PCDT, SUS, and specific Brazilian Consensus guidelines) throughout the vignettes, questions, and explanations.

What clinical guidelines are most heavily tested in the FBG examination?

The exam heavily references the Brazilian Consensus on H. pylori Infection (FBG), the Clinical Protocol and Therapeutic Guidelines (PCDT) for Viral Hepatitis B and C (Ministério da Saúde), Baveno VII Consensus on Portal Hypertension, STRIDE-II Treat-to-Target in IBD, Chicago Classification v4.0 for Esophageal Motility, Lyon Consensus 2.0 for GERD, Revised Atlanta Classification for Acute Pancreatitis, Tokyo Guidelines (TG18) for Cholangitis, and Rome IV criteria for Disorders of Gut-Brain Interaction.